Discontinued — last reported Q3 '23
CRCL Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 67.4% to $125.00K in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $384.00K | $384.00K | $125.00K |
| QoQ Change | — | +0.0% | -67.4% |